Rep. Brad Knott Buys CompoSecure, Inc. (NASDAQ:CMPO) Shares

Representative Brad Knott (R-North Carolina) recently bought shares of CompoSecure, Inc. (NASDAQ:CMPO). In a filing disclosed on February 25th, the Representative disclosed that they had bought between $1,001 and $15,000 in CompoSecure stock on January 14th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 1” account.

Representative Brad Knott also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of CompoSecure (NASDAQ:CMPO) on 1/10/2025.
• Sold $15,001 – $50,000 in shares of Oramed Pharmaceuticals (NASDAQ:ORMP) on 1/10/2025.

CompoSecure Trading Up 3.0 %

CMPO opened at $15.80 on Thursday. CompoSecure, Inc. has a 12-month low of $4.61 and a 12-month high of $17.71. The business’s fifty day simple moving average is $15.46 and its 200-day simple moving average is $14.51. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of -35.91, a PEG ratio of 2.63 and a beta of 0.78.

Insider Buying and Selling at CompoSecure

In related news, COO Gregoire Maes sold 55,137 shares of CompoSecure stock in a transaction dated Friday, December 6th. The stock was sold at an average price of $16.40, for a total transaction of $904,246.80. Following the completion of the sale, the chief operating officer now owns 762,009 shares of the company’s stock, valued at $12,496,947.60. The trade was a 6.75 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Resolute Compo Holdings Llc bought 221,186 shares of the firm’s stock in a transaction that occurred on Wednesday, February 12th. The shares were purchased at an average cost of $15.01 per share, with a total value of $3,320,001.86. Following the acquisition, the director now directly owns 221,186 shares of the company’s stock, valued at approximately $3,320,001.86. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 659,376 shares of company stock worth $10,429,021 and sold 156,337 shares worth $2,525,818. 74.99% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On CompoSecure

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Verition Fund Management LLC purchased a new stake in CompoSecure in the third quarter valued at about $798,000. Geode Capital Management LLC raised its stake in CompoSecure by 34.1% in the third quarter. Geode Capital Management LLC now owns 585,746 shares of the company’s stock valued at $8,214,000 after buying an additional 148,833 shares during the last quarter. JPMorgan Chase & Co. raised its stake in CompoSecure by 555.0% in the third quarter. JPMorgan Chase & Co. now owns 51,949 shares of the company’s stock valued at $728,000 after buying an additional 44,018 shares during the last quarter. State Street Corp raised its stake in CompoSecure by 20.1% in the third quarter. State Street Corp now owns 395,691 shares of the company’s stock valued at $5,548,000 after buying an additional 66,232 shares during the last quarter. Finally, Tyro Capital Management LLC purchased a new stake in CompoSecure in the third quarter valued at about $27,978,000. 37.56% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CMPO has been the topic of a number of recent research reports. Benchmark reissued a “buy” rating and set a $17.00 price target on shares of CompoSecure in a research report on Tuesday, November 12th. JPMorgan Chase & Co. increased their price target on CompoSecure from $12.00 to $16.00 and gave the stock a “neutral” rating in a research report on Monday, December 2nd. TD Cowen initiated coverage on CompoSecure in a research report on Wednesday, December 18th. They set a “buy” rating and a $20.00 price target on the stock. B. Riley increased their price target on CompoSecure from $18.00 to $23.00 and gave the stock a “buy” rating in a research report on Monday, November 11th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $16.00 price objective on shares of CompoSecure in a research report on Monday, November 11th. One equities research analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $16.81.

About Representative Knott

Brad Knott (Republican Party) is a member of the U.S. House, representing North Carolina’s 13th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Knott (Republican Party) ran for election to the U.S. House to represent North Carolina’s 13th Congressional District. He won in the general election on November 5, 2024.

Brad Knott grew up in Raleigh, North Carolina. He earned a J.D. from Wake Forest University. Knott’s career experience includes working as a federal prosecutor in the U.S. Attorney’s Office for Eastern North Carolina.

CompoSecure Company Profile

CompoSecure, Inc manufactures and designs metal, composite, and proprietary financial transaction cards in the United States and internationally. Its primary metal form factors include embedded, metal veneer lite, metal veneer, and full metal products. The company also offers Arculus Cold Storage Wallet, a three-factor authentication solution, which supports specific digital assets, including Bitcoin, Ethereum, non-fungible tokens and others.